The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.
about
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Chemerin: A comprehensive review elucidating the need for cardiovascular researchDysregulation of Chemokine/Chemokine Receptor Axes and NK Cell Tissue Localization during DiseasesRIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary MetastasisA role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Prognostic significance of serum chemerin levels in patients with non-small cell lung cancerSerum chemerin levels are independently associated with quality of life in colorectal cancer survivors: A pilot study.Indicators of responsiveness to immune checkpoint inhibitorsChimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor ImmunityRARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma.De novo chemoattractants form supramolecular hydrogels for immunomodulating neutrophils in vivo.In vivo administration of a JAK3 inhibitor to chronically siv infected rhesus macaques leads to NK cell depletion associated with transient modest increase in viral loads.Increased expression of chemerin in squamous esophageal cancer myofibroblasts and role in recruitment of mesenchymal stromal cellsPotential Therapeutic Effect of Natural Killer Cells on Doxorubicin-Resistant Breast Cancer Cells In Vitro.Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.Chemerin Stimulates Vascular Smooth Muscle Cell Proliferation and Carotid Neointimal Hyperplasia by Activating Mitogen-Activated Protein Kinase SignalingNatural killer cells in non-hematopoietic malignanciesRole of dendritic cells in the regulation of antitumor immunityTargeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexiaChemerin regulation and role in host defense.Towards an integrative approach to understanding the role of chemerin in human health and disease.Shaping of NK cell responses by the tumor microenvironmentEffect of tumor cells and tumor microenvironment on NK-cell function.Therapeutic potential and challenges of natural killer cells in treatment of solid tumorsSenescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration.Chemerin neutralization blocks hematopoietic stem cell osteoclastogenesis.Microfluidic-based, live-cell analysis allows assessment of NK-cell migration in response to crosstalk with dendritic cells.Anti-tumor activity of CpG-ODN aerosol in mouse lung metastases.Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulation.Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma.Interleukin-17D mediates tumor rejection through recruitment of natural killer cellsOverexpression of chemerin was associated with tumor angiogenesis and poor clinical outcome in squamous cell carcinoma of the oral tongue.Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia.Age-associated and therapy-induced alterations in the cellular microenvironment of experimental gliomas.Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo.International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.A tribute to the life and career of Holbrook Kohrt.Cardiopulmonary fitness, adiponectin, chemerin associated fasting insulin level in colorectal cancer patients.Serum and salivary levels of chemerin and MMP-9 in oral squamous cell carcinoma and oral premalignant lesions.
P2860
Q26746478-7C9142B2-AF21-4308-B0FE-2EDD1E2958E8Q26799489-F463B128-C98A-4CE8-96FB-62F4F86346F1Q28079140-EC1DD0AE-97EE-42DD-8448-3F48FDA73DCAQ28275702-979467A2-A91D-45AC-AFC8-BD9F3F0CC950Q30384899-897E70BB-8FAD-4CD0-BC85-415E6289092CQ33618374-5D3C60CD-8D97-4989-9E62-FA523C875F7EQ33643052-FF3ED5F1-09E9-41C7-9779-2B8CDB297159Q33678048-240FA06C-68B4-48B3-B212-31E32E54C50DQ33700795-4328637B-7131-4DA8-BE7A-4F6B8D2C54E2Q33826424-3B349C62-5122-4233-8D33-FA94E08C0A6AQ34764456-C72B0496-118A-4963-9F5F-FB564C0508F3Q34907640-29D82AA1-E0C8-4120-996E-2A3503130969Q35225647-D0C415EF-41E0-473A-837D-975DB9DB4B03Q35752181-4841C183-FE7E-4465-852C-336DD5E61E04Q35970632-47A75B53-610E-4B3E-ABE3-DEDF27727D86Q36177196-5CB3E303-6C3B-4F88-9EE6-D13F680B78F8Q36486204-978345D2-83E6-4235-97B3-060C3A48711FQ36845842-22D0AA16-6389-40FA-9696-7C37EC897CD8Q37191935-95734E8D-AFCD-402A-BBA7-CCA93023D739Q37651088-A0D56071-9F75-4940-BE67-177053570B18Q38065313-CCCA5467-904C-4620-B03F-441763586CF1Q38067641-3DA61D16-7BB8-44C8-968B-40A37912976FQ38207947-E5982724-0624-40CA-8140-32FDBBEA0C37Q38478878-D60B7763-EB9A-494E-8CA4-9412098636E2Q38728052-12BC1D58-7338-431E-A27D-A5BB607BD102Q39139785-8F4AA605-CF89-44F7-816B-A28D7A35B057Q39171809-5AAC1177-86B0-495B-889B-935044F3182BQ39210540-7590EE67-B2C1-489D-BE16-A58CEAC12C1BQ40348056-B05092B3-A33A-469E-B6E8-C619399E7510Q41010316-462D24DE-1F4F-4535-A829-2E4BBB143C57Q41897122-93996B00-EC47-4530-832B-C4F7A0D8BAC4Q44240100-0D2E427E-3C61-40CC-8573-F62BDE0FEF36Q46670726-77F15BB2-EA6C-4B36-BE65-C8AB73A878B5Q47100706-82BB7A4C-E595-43DA-93ED-BC27AD36C462Q47147970-8DA609F4-65F4-42E0-8129-16CA9DA31C8DQ47253151-9C73FA1B-935E-498D-A74C-80D04E294445Q47752545-727B0A78-74DD-4C18-B91B-2A31576C17F8Q51289723-5BE245A3-000D-4C0A-B0EA-E784A67BE965Q53763554-03DBEC55-EF96-4074-A624-78096A78BAE9
P2860
The chemoattractant chemerin suppresses melanoma by recruiting natural killer cell antitumor defenses.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The chemoattractant chemerin s ...... iller cell antitumor defenses.
@ast
The chemoattractant chemerin s ...... iller cell antitumor defenses.
@en
type
label
The chemoattractant chemerin s ...... iller cell antitumor defenses.
@ast
The chemoattractant chemerin s ...... iller cell antitumor defenses.
@en
prefLabel
The chemoattractant chemerin s ...... iller cell antitumor defenses.
@ast
The chemoattractant chemerin s ...... iller cell antitumor defenses.
@en
P2093
P2860
P356
P1476
The chemoattractant chemerin s ...... killer cell antitumor defenses
@en
P2093
Abdolhossein Edalati
Alison K Holzer
Andrew J Gentles
Brian A Zabel
Christina D Swanson
Eugene C Butcher
Gizette V Sperinde
Holbrook E Kohrt
Husein A Hadeiba
Justin Monnier
P2860
P304
P356
10.1084/JEM.20112124
P407
P577
2012-07-02T00:00:00Z